These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37204842)

  • 1. TSH level as a risk factor of thyroid malignancy for nodules in euthyroid patients.
    Alaraifi AK; Alessa M; Hijazi LO; Alayed AM; Alsalem AA
    Acta Otorhinolaryngol Ital; 2023 Jun; 43(3):183-188. PubMed ID: 37204842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system.
    Baser H; Topaloglu O; Tam AA; Evranos B; Alkan A; Sungu N; Dumlu EG; Ersoy R; Cakir B
    Endocrine; 2016 Aug; 53(2):520-9. PubMed ID: 26972701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution.
    Zafón C; Obiols G; Mesa J
    Endocrinol Nutr; 2015 Jan; 62(1):24-8. PubMed ID: 25066642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Thyroid Cancer in Euthyroid Asymptomatic Patients with Thyroid Nodules with an Emphasis on Family History of Thyroid Cancer.
    Hwang SH; Kim EK; Moon HJ; Yoon JH; Kwak JY
    Korean J Radiol; 2016; 17(2):255-63. PubMed ID: 26957911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum TSH as a predictor of malignancy in indeterminate thyroid nodules.
    Amado A; Castro B; Torre AP; Graça S; Tavares A; Póvoa A; Soares C; Gonçalves G
    Ann R Coll Surg Engl; 2022 May; 104(5):380-384. PubMed ID: 34939834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum TSH is not a risk factor for malignancy of pediatric thyroid nodules.
    Wang G; Ren N; Wang S; Zhang X; Li Y; Sun N; Liu Q; Zhang J; Song W; Ni X
    Endocr Relat Cancer; 2021 Apr; 28(4):247-255. PubMed ID: 33690161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid Nodule Management: Thyroid-Stimulating Hormone, Ultrasound, and Cytological Classification System for Predicting Malignancy.
    Al Dawish MA; Alwin Robert A; Thabet MA; Braham R
    Cancer Inform; 2018; 17():1176935118765132. PubMed ID: 29581701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
    Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
    Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSH Level and Risk of Malignancy in Patients with Bethesda Category IV Thyroid Nodules.
    Fernández-Trujillo C; Pérez-Zaballos J; Rodríguez-Pérez CA; López-Plasencia Y; Marrero-Arencibia D; Cabrera-Galván JJ; Boronat M
    Horm Cancer; 2020 Aug; 11(3-4):200-204. PubMed ID: 32266672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum TSH Level as a Simple Efficient Tool to Assess the Risk of Thyroid Malignancy in Euthyroid Patients with Indeterminate Cytology - A Cohort Study.
    Vinod A; Ramachandran R; Pillai AV; Padmanabhan DS; Ravindran GC; Babu MJC; Jacob P; Nair GC
    Indian J Endocrinol Metab; 2022; 26(5):446-452. PubMed ID: 36618514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule.
    Moon SS; Lee YS; Lee IK; Kim JG
    Head Neck; 2012 Jul; 34(7):949-52. PubMed ID: 22127951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy rates for Bethesda III and IV thyroid nodules: a retrospective study of the correlation between fine-needle aspiration cytology and histopathology.
    Yaprak Bayrak B; Eruyar AT
    BMC Endocr Disord; 2020 Apr; 20(1):48. PubMed ID: 32293401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin concentration in children with isolated thyroid nodules.
    Mussa A; Salerno MC; Bona G; Wasniewska M; Segni M; Cassio A; Vigone MC; Gastaldi R; Iughetti L; Santanera A; Capalbo D; Matarazzo P; De Luca F; Weber G; Corrias A
    J Pediatr; 2013 Nov; 163(5):1465-70. PubMed ID: 23972643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological correlation of serum TSH in patients with thyroid nodule.
    Mondal HP; Sen S; Sasmal S; Ghosal PK; Mukhopadhyay SK; Mukhopadhyay M
    J Indian Med Assoc; 2011 May; 109(5):330, 335, 338. PubMed ID: 22187768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.
    Hulikal N; Re A; Banoth M; Chowhan AK; Yutla M; Sachan A
    Acta Otorhinolaryngol Ital; 2020 Feb; 40(1):33-37. PubMed ID: 32275647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules.
    Polyzos SA; Kita M; Efstathiadou Z; Poulakos P; Slavakis A; Sofianou D; Flaris N; Leontsini M; Kourtis A; Avramidis A
    J Cancer Res Clin Oncol; 2008 Sep; 134(9):953-60. PubMed ID: 18327610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The McGill Thyroid Nodule Score's (MTNS+) role in the investigation of thyroid nodules with benign ultrasound guided fine needle aspiration biopsies: a retrospective review.
    Khalife S; Bouhabel S; Forest VI; Hier MP; Rochon L; Tamilia M; Payne RJ
    J Otolaryngol Head Neck Surg; 2016 May; 45(1):29. PubMed ID: 27142264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum TSH levels as a predictor of malignancy in thyroid nodules: A prospective study.
    Golbert L; de Cristo AP; Faccin CS; Farenzena M; Folgierini H; Graudenz MS; Maia AL
    PLoS One; 2017; 12(11):e0188123. PubMed ID: 29145466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Nodule Size at Ultrasound as a Predictor of Malignancy and Final Pathologic Size.
    Cavallo A; Johnson DN; White MG; Siddiqui S; Antic T; Mathew M; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
    Thyroid; 2017 May; 27(5):641-650. PubMed ID: 28052718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules.
    Boi F; Minerba L; Lai ML; Marziani B; Figus B; Spanu F; Borghero A; Mariotti S
    J Endocrinol Invest; 2013 May; 36(5):313-20. PubMed ID: 22931861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.